MR (n = 43) n (%) | C (n = 44) n (%) | MR vs C | |||||
---|---|---|---|---|---|---|---|
Baseline | Week 12 | P a | Baseline | Week 12 | P a | P b | |
Weight reduction > 5% | - | 33 (76.7%) | - | - | 22 (50.0%) | - | 0.010 |
WC > 88 cm | 31 (72.9%) | 19 (44.2%) | 0.009 | 37 (84.1%) | 24 (54.5%) | 0.003 | 0.429 |
BP systolic ≥ 130 mmHg | 28 (65.1%) | 15 (34.9%) | 0.005 | 20 (45.5%) | 12 (27.3%) | 0.076 | 0.263 |
BP diastolic ≥ 85 mmHg | 13 (30.2%) | 9 (20.9%) | 0.323 | 6 (13.6%) | 6 (13.6%) | 1.000 | 0.229 |
BP ≥ 130/85 mmHg | 12 (27.9%) | 5 (11.6%) | 0.058 | 6 (13.6%) | 5 (11.4%) | 0.747 | 0.439 |
TG ≥ 150 mg/dl | 14 (41.2%)c | 16 (47.1%)c | 0.651 | 15 (44.1%)c | 13 (38.2%)c | 0.647 | 0.897 |
HDL-C < 50 mg/dl | 11 (32.4%)c | 12 (35.3%)c | 0.808 | 8 (23.5%)c | 11 (32.4%)c | 0.437 | 0.851 |
Fasting glucose ≥ 110 mg/dl | 2 (5.9%)c | 2 (5.9%)c | 1.000 | 3 (8.8%)c | 1 (2.9%)c | 0.306 | 0.906 |
Hypertriglyceridemic waistd | 12 (35.3%)c | 7 (20.6%)c | 0.194 | 14 (41.2%)c | 7 (20.6)c | 0.080 | 0.984 |
Atherogenic dyslipidemiae | 6 (17.6%)c | 7 (20.6%)c | 0.763 | 4 (11.8%)c | 3 (8.8%)c | 0.694 | 0.490 |